CVRx, Inc. (CVRX) stock
CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3091% below fair value
$0.61−0.00 (-0.33%)
Close on Nov 17, 2026Market cap $16.28MP/E –Yield –
CVRx price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
CVRx's price to sales ratio was 0.3× on Nov 11, 2026, against 4.6× a year earlier. Over the last 5 years it ranged from 0.3× to 21.7×, with a median of 8.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.3× | −3.0 |
| 2025 | Dec 31, 2025 | 3.3× | −3.2 |
| 2024 | Dec 31, 2024 | 6.5× | −12.1 |
| 2023 | Dec 29, 2023 | 18.6× | −1.3 |
| 2022 | Dec 30, 2022 | 19.9× | −1.8 |
| 2021 | Dec 31, 2021 | 21.7× | – |
See a number that looks wrong?